FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045341648> ?p ?o ?g. }

• W2045341648 endingPage "280" @default.
• W2045341648 startingPage "269" @default.
• W2045341648 abstract "Journal of Autonomic PharmacologyVolume 16, Issue 5 p. 269-280 Changes in cardiovascular responsiveness to dopexamine and β1- and β2-adrenoceptor function after the chronic treatment of β-adrenoceptor antagonists and agonists in anaesthetized dogs D. H. -T. Chang, D. H. -T. Chang Department of Pharmacology, The University of Sydney, N. S. W. 2006, AustraliaSearch for more papers by this authorR. Einstein, Corresponding Author R. Einstein Department of Pharmacology, The University of Sydney, N. S. W. 2006, AustraliaProf R. EinsteinSearch for more papers by this author D. H. -T. Chang, D. H. -T. Chang Department of Pharmacology, The University of Sydney, N. S. W. 2006, AustraliaSearch for more papers by this authorR. Einstein, Corresponding Author R. Einstein Department of Pharmacology, The University of Sydney, N. S. W. 2006, AustraliaProf R. EinsteinSearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1474-8673.1996.tb00361.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References BASS, A. S., KOHLI, J. D., LUBBERS, N. and GOLDBERG, L. L. (1987). Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J. Pharmacol. Exp. Ther., 242, 940–944. BLAKE, D. W., WAY, D., TRIGG, L. and MCGRATH, B. P. (1994). Regional blood flow effects of dopexamine vs. enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure. Cardiovasc. Res., 28, 710–714. BOUDOULAS, H., LEWIS, R. P., KATES, R. E. and ALAMANGAS, G. (1977). Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann. Intern. Med., 87, 433–436. BROOM, O. -E., DAUL, A. E., MARINA, M. -R., BOOMSMA, F., VELD, A. M. and MICHEL, M. C. (1990). Agonist-induced desensitization of β-adrenoceptor function in humans. Circulation, 81, 914–921. BRODDE, O. -E. (1991). β1- and β2-adrenoceptors in the human heart: Properties, function and alterations in chronic heart failure. Pharmacol. Rev., 43(2), 203–242. BRODDE, O. -E. (1992). Chronic β1-blocker treatment and cardiac β2-adrenoceptor function. Am. Heart J., 123, 1727–1728. BROWN, R. A., DIXON, J., FARMER, J. B., HALL, J. C., HUMPHRIES, R. G., INCE, F., O'CONNOR, S. E., SIMPSON, W. T. and SMITH, G. W. (1985). Dopexamine: a novel agonist at peripheral dopamine receptors and β2-adrenoceptors. Br. J. Pharmacol., 85, 599–608. EINSTEIN, R., MIHAILIDOU, A. S. and RICHARDSON, D. P. (1987). Positive inotropic effects of histamine in anaesthetised dogs. Br. J. Pharmacol., 92, 445–450. EINSTEIN, R., ABDUL-HUSSEIN, N., WONG, T. -W., CHANG, D. H. -T., MATTHEWS, R. and RICHARDSON, D. P. (1994). Cardiovascular actions of dopexamine in anaesthetised and conscious dogs. Br. J. Pharmacol., 111, 199–204. FERRO, A., KAUMANN, A. J. and BROWN, M. J. (1993). β1- and β2-adrenoceptor-mediated relaxation in human internal mammary artery and saphenous vein: unchanged β- and α-adrenoceptor responsiveness after chronic β1-adrenoceptor blockade. Br. J. Pharmacol., 109, 1053–1058. FRANCIS, G. S. and COHN, J. N. (1986). The autonomic nervous system in congestive heart failure. Ann. Rev. Med., 37, 235–247. GOODMAN, A. H., ANGUS, J. A., EINSTEIN, R. and COBBIN, L. B. (1972). A device for measuring myocardial contractility. Med. Biol. Engng., 10, 483–495. HALL, J. A., KAUMANN, A. J., WELLS, F. C. and BROWN, M. J. (1988). Beta adrenoreceptor subtypes in human atrium: Selective regulation of β2-adrenoreceptors by atenolol (abstract). Br. J. Pharmacol., 93, 116P. HALL, J. A., KAUMANN, A. J. and BROWN, M. J. (1990). Selective β1-adrenoreceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through β2-adrenoreceptors in human atrial myocardium. Circ. Res., 66, 1610–1623. HALL, J. A., PETCH, M. C. and BROWN, M. J. (1991). In vivo demonstration of cardiac β2-acitenoreceptor sensitization by β1-antagonist treatment. Circ. Res., 69, 959–964. MARTIN, S. W. and BROADLEY, K. J. (1994). Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, β1- and β2-receptor-mediated responses. Br. J. Pharmacol., 112, 595–603. MICHEL, M. C., PINGSMANN, A., BECKERINGH, J. J., ZERKOWSKI, H. -R., DOETSCH, N. and BRODDE, O. -E. (1988). Selective regulation of β1 and β2 adrenoreceptors in the human heart by chronic β-adrenoreceptor antagonist treatment. Br. J. Pharmacol., 94, 685–692. MOLENAAR, P., SMOLICH, J. J., RUSSELL, F. D., MCMARTIN, L. R. and SUMMERS, R. J. (1990). Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J. Pharmacol. Exp. Ther., 255, 393–400. MOTOMURA, S., DEIGHTON, N. M., ZERKOWSKI, H. -R., DOETSCH, N., MICHEL, M. C. and BRODDE, O. -E. (1990). Chronic β1-antagonist treatment sensitizes β2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium. Br. J. Phamacol., 101, 363–369. NANOFF, C., FREISSMUTH, M., TUISL, E. and SCHUTZ, W. (1989). A different desensitization pattern of cardiac β-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J. Cardiovasc. Pharmacol., 13, 198–203. PANFILOV, V., WAHLQVIST, I. and OLSSON, G. (1995). Use of beta-adrenoceptor blockers in patients with congestive heart failure. Cardiovasc. Drugs Ther., 9, 273–287. ROSS, P. J., LEWIS, M. J., SHERIDAN, D. J. and HENDERSON, A. H. (1981). Adrenergic hypersensitivity after beta-blocker withdrawal. Br. Heart J., 45, 637–642. SARSERO, D. and MOLENAAR, P. (1995). Effects of chronic infusion of (-)-isoprenaline on rat cardiac muscarinic (M2)- cholinoceptors and β1- and β2-adrenoceptors. J. Auton. Pharmacol. 15, 239–255. SMITH, G. W., HALL, J. C., FARMER, J. B. and SIMPSON, W. T. (1987). Cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and β2-adrenoceptors in the dog. J. Pharm. Pharmacol., 39, 636–641. SUMMERS, R. J., MOLENAAR, P., RUSSELL, F., ELNATAN, J., JONES, C. R., BUXTON, B. F., CHANG, V. and HAMBLEY, J. (1989). Coexistence and localization of β1- and β2-adrenoceptors in the human heart. Eur. Heart J., 10(Suppl. B), 11–22. UEMURA, N., NEJIMA, J., HINTZE, T. H., VATNER, D. E., GRAHAM, R. M., HOMCY, C. J. and VATNER, S. F. (1988). Desensitization to norepinephrine and isoproterenol in conscious dogs. Physiologist, 31, A113. VAN VELDHUISEN, D. J., GIRBES, A. R. J., DE GRAEFF, P. A., and LIE, K. I. (1992). Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure. Int. J. Cardiol., 37, 292–300. WEBB, J. G., NEWMAN, W. H., WALLS, T. and DANIELL, H. B. (1981). Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs. J. Cardiovasc. Pharmacol., 3, 622–635. Citing Literature Volume16, Issue5October 1996Pages 269-280 ReferencesRelatedInformation" @default.
• W2045341648 created "2016-06-24" @default.
• W2045341648 creator A5019334097 @default.
• W2045341648 creator A5090399610 @default.
• W2045341648 date "1996-10-01" @default.
• W2045341648 modified "2023-09-24" @default.
• W2045341648 title "Changes in cardiovascular responsiveness to dopexamine and β1- and β2-adrenoceptor function after the chronic treatment of β-adrenoceptor antagonists and agonists in anaesthetized dogs" @default.
• W2045341648 cites W1974435566 @default.
• W2045341648 cites W1983027650 @default.
• W2045341648 cites W1983992891 @default.
• W2045341648 cites W1988112250 @default.
• W2045341648 cites W1989889988 @default.
• W2045341648 cites W1998712345 @default.
• W2045341648 cites W2004198573 @default.
• W2045341648 cites W2038613050 @default.
• W2045341648 cites W2049763176 @default.
• W2045341648 cites W2063801876 @default.
• W2045341648 cites W2065967144 @default.
• W2045341648 cites W2067015973 @default.
• W2045341648 cites W2070282618 @default.
• W2045341648 cites W2071572908 @default.
• W2045341648 cites W2076680480 @default.
• W2045341648 cites W2093477029 @default.
• W2045341648 cites W2094168387 @default.
• W2045341648 cites W2106243945 @default.
• W2045341648 cites W2108826286 @default.
• W2045341648 cites W2144145208 @default.
• W2045341648 cites W2286878777 @default.
• W2045341648 cites W2415224669 @default.
• W2045341648 doi "https://doi.org/10.1111/j.1474-8673.1996.tb00361.x" @default.
• W2045341648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9023671" @default.
• W2045341648 hasPublicationYear "1996" @default.
• W2045341648 type Work @default.
• W2045341648 sameAs 2045341648 @default.
• W2045341648 citedByCount "3" @default.
• W2045341648 crossrefType "journal-article" @default.
• W2045341648 hasAuthorship W2045341648A5019334097 @default.
• W2045341648 hasAuthorship W2045341648A5090399610 @default.
• W2045341648 hasConcept C126322002 @default.
• W2045341648 hasConcept C164705383 @default.
• W2045341648 hasConcept C170493617 @default.
• W2045341648 hasConcept C2778151854 @default.
• W2045341648 hasConcept C2909341992 @default.
• W2045341648 hasConcept C40465926 @default.
• W2045341648 hasConcept C42219234 @default.
• W2045341648 hasConcept C71924100 @default.
• W2045341648 hasConcept C98274493 @default.
• W2045341648 hasConceptScore W2045341648C126322002 @default.
• W2045341648 hasConceptScore W2045341648C164705383 @default.
• W2045341648 hasConceptScore W2045341648C170493617 @default.
• W2045341648 hasConceptScore W2045341648C2778151854 @default.
• W2045341648 hasConceptScore W2045341648C2909341992 @default.
• W2045341648 hasConceptScore W2045341648C40465926 @default.
• W2045341648 hasConceptScore W2045341648C42219234 @default.
• W2045341648 hasConceptScore W2045341648C71924100 @default.
• W2045341648 hasConceptScore W2045341648C98274493 @default.
• W2045341648 hasIssue "5" @default.
• W2045341648 hasLocation W20453416481 @default.
• W2045341648 hasLocation W20453416482 @default.
• W2045341648 hasOpenAccess W2045341648 @default.
• W2045341648 hasPrimaryLocation W20453416481 @default.
• W2045341648 hasRelatedWork W1934280625 @default.
• W2045341648 hasRelatedWork W1966839547 @default.
• W2045341648 hasRelatedWork W1976234278 @default.
• W2045341648 hasRelatedWork W2052453588 @default.
• W2045341648 hasRelatedWork W2058478536 @default.
• W2045341648 hasRelatedWork W2127219007 @default.
• W2045341648 hasRelatedWork W2254677881 @default.
• W2045341648 hasRelatedWork W2306155625 @default.
• W2045341648 hasRelatedWork W2315166476 @default.
• W2045341648 hasRelatedWork W4289968147 @default.
• W2045341648 hasVolume "16" @default.
• W2045341648 isParatext "false" @default.
• W2045341648 isRetracted "false" @default.
• W2045341648 magId "2045341648" @default.
• W2045341648 workType "article" @default.